Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Rtw Investments, Lp
Form 13F · Q2 2026

Rtw Investments, Lp

CIK 1493215申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$117.1亿
申报组合市值
84
持仓数量
12
Quarters on record
Top 50
持仓数量

Rtw Investments, Lp——持仓

共 84 个持仓中的前 50 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1MDGL Madrigal Pharmaceuticals Inc2.0M+0.0%$10.7亿9.1%
2ARGX Argenx Se709,446+0.0%$6.6亿5.6%
3PTCT Ptc Therapeutics Inc7.7M+0.0%$6.3亿5.4%
4PTGX Protagonist Therapeutics Inc5.1M+0.0%$6.2亿5.3%
5CGON Cg Oncology Inc8.5M+21.9%$6.0亿5.2%
6INSM Insmed Inc4.8M+0.0%$5.2亿4.4%
7TNGX Tango Therapeutics Inc13.9M+4.5%$4.3亿3.7%
8SYRE Spyre Therapeutics Inc4.3M+1.9%$3.8亿3.2%
9CELC Celcuity Inc3.3M+8.7%$3.5亿3.0%
10ERAS Erasca Inc17.9M+11.1%$3.3亿2.8%
11RDNT Radnet Inc4.8M+13.1%$3.0亿2.6%
12ORKA Oruka Therapeutics Inc3.1M+52.5%$3.0亿2.6%
13NTRA Natera Inc1.0M−20.0%$2.7亿2.3%
14RARE Ultragenyx Pharmaceutical In7.8M+113.7%$2.6亿2.2%
15IRTC Irhythm Holdings Inc2.2M+30.8%$2.6亿2.2%
16CYTK Cytokinetics Inc2.9M+5.2%$2.4亿2.1%
17KLRA Kailera Therapeutics Inc10.8M—$2.4亿2.0%
18ESTA Establishment Labs Hldgs Inc2.7M+0.0%$2.3亿1.9%
19GH Guardant Health Inc1.5M+0.0%$2.2亿1.9%
20NBIX Neurocrine Biosciences Inc1.3M+19.4%$2.1亿1.8%
21TARS Tarsus Pharmaceuticals Inc3.4M+0.3%$2.1亿1.8%
22STOK Stoke Therapeutics Inc5.6M+0.0%$1.8亿1.6%
23QURE Uniqure Nv3.9M+52.4%$1.8亿1.5%
24ACAD Acadia Pharmaceuticals Inc7.1M+0.0%$1.8亿1.5%
25RGEN Repligen Corp1.2M+2.9%$1.7亿1.4%
26URGN Urogen Pharma Ltd4.5M+0.0%$1.7亿1.4%
27GHRS Gh Research Plc5.9M+0.0%$1.6亿1.4%
28IMCR Immunocore Hldgs Plc4.9M+0.0%$1.5亿1.3%
29CMPS Compass Pathways Plc10.7M+0.6%$1.5亿1.3%
30IMTX Immatics N.V12.9M+0.6%$1.3亿1.1%
31ZLAB Zai Lab Ltd6.6M+0.0%$1.2亿1.1%
32IMVT Immunovant Inc3.2M+0.0%$1.2亿1.0%
33BLTE Belite Bio Inc715,332+0.0%$1.1亿0.9%
34XNCR Xencor Inc6.8M+0.0%$1.1亿0.9%
35TSHA Taysha Gene Therapies Inc13.6M−0.9%$9235万0.8%
36COGT Cogent Biosciences Inc2.3M−57.7%$8936万0.8%
37ALKS Alkermes Plc1.7M+0.0%$8762万0.7%
38GPCR Structure Therapeutics Inc1.6M—$8627万0.7%
39REPL Replimune Group Inc7.4M+0.7%$8205万0.7%
40CSTL Castle Biosciences Inc2.8M+0.7%$6626万0.6%
41CADL Candel Therapeutics Inc6.4M+0.0%$6615万0.6%
42RCKT Rocket Pharmaceuticals Inc17.7M+0.0%$6049万0.5%
43KOD Kodiak Sciences Inc1.5M+0.0%$5797万0.5%
44AKTS Aktis Oncology Inc1.6M+0.0%$5131万0.4%
45AXGN Axogen Inc1.0M—$4672万0.4%
46DHR Danaher Corp Del230,000—$4381万0.4%
47CGEM Cullinan Therapeutics Inc2.4M+38.6%$4305万0.4%
48NGNE Neurogene Inc1.4M+0.0%$4285万0.4%
49HNGE Hinge Health Inc500,000−74.1%$4150万0.4%
50OBIO Orchestra Biomed Hldgs Inc9.6M+15.0%$4123万0.4%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。